Scientists at The Scripps Research Institute have discovered a new vulnerability in the HIV, which can be attacked by the human immune system so it neutralizes a wide variety of HIV strains.
“HIV has very few known sites of vulnerability, but in this work we’ve described a new one, and we expect it will be useful in developing a vaccine,” said Dennis R. Burton, professor in TSRI’s Department of Immunology and Microbial Science.
The study is part of a larger scale project funded by the International AIDS Vaccine Initiative and the National Institutes of Health to develop an effective vaccine against HIV.
The Business Journal is the premier business publication in San Diego. Every day online and each Monday in print, the Business Journal reports on how local business operate and why businesses leaders make the decisions they do. Every story is a dose of insight into how to run a better, more efficient, more profitable business.